Is ADGI or RYLD a better dividend investment in 2026?

ADGI currently yields 43.10% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: ADGI offers higher current income.

What is the dividend yield difference between ADGI and RYLD?

ADGI has a forward dividend yield of 43.10% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 30.71 percentage points.

Home › Compare › ADGI vs RYLD

ADGI vs RYLD: Dividend Comparison 2026

ADGI yields 43.10% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADGI wins by $228.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADGI

● Live price

43.10%

Share price

$4.64

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$274.2K

Annual income

$49,280.46

Full ADGI calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — ADGI vs RYLD

📍 ADGI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADGI	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADGI + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADGI pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADGI

Annual income on $10K today (after 15% tax)

$3,663.79/yr

After 10yr DRIP, annual income (after tax)

$41,888.39/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, ADGI beats the other by $39,607.86/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADGI + RYLD for your $10,000?

ADGI: 50%RYLD: 50%

100% RYLD50/50100% ADGI

Portfolio after 10yr

$159.7K

Annual income

$25,981.72/yr

Blended yield

16.27%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADGI right now

ADGI

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADGI buys

RYLD buys

No recent congressional trades found for ADGI or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADGIRYLD

Forward yield	43.10% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$274.2K ✓	$45.3K
Annual income after 10y	$49,280.46 ✓	$2,682.98
Total dividends collected	$210.7K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ADGI vs RYLD ($10,000, DRIP)

Year	ADGI Portfolio	ADGI Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$15,010	$4,310.34	$11,939	$1,239.34	+$3.1K → ADGI
2	$22,108	$6,046.71	$14,158	$1,382.89	+$8.0K → ADGI
3	$31,979	$8,323.18	$16,682	$1,532.59	+$15.3K → ADGI
4	$45,469	$11,251.72	$19,537	$1,687.64	+$25.9K → ADGI
5	$63,603	$14,951.67	$22,752	$1,847.20	+$40.9K → ADGI
6	$87,602	$19,546.64	$26,355	$2,010.43	+$61.2K → ADGI
7	$118,895	$25,160.75	$30,376	$2,176.45	+$88.5K → ADGI
8	$159,132	$31,914.57	$34,847	$2,344.43	+$124.3K → ADGI
9	$210,192	$39,920.85	$39,800	$2,513.54	+$170.4K → ADGI
10	$274,186	$49,280.46	$45,269	$2,682.98	+$228.9K → ADGI

ADGI vs RYLD: Complete Analysis 2026

ADGI — Stock

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Full ADGI Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ADGI vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADGI vs SCHD ADGI vs JEPI ADGI vs O ADGI vs KO ADGI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.